FDA's Medical Countermeasure Program Among Senate Funding Priorities
• By Cathy Dombrowski
FDA should spend $19 million of an increase in non-user fee funding in fiscal 2012 on the agency’s medical countermeasures effort, the Senate Appropriations Committee recommends in the report that accompanies the Agriculture/FDA appropriations bill approved by the panel Sept 8.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
